Boston Scientific: A$2.7m–4.2m Margin Opportunity

Case study summary

Pricing Insight worked with selected Boston Scientific Australia and New Zealand teams to assess pricing capability, strengthen value communication and improve pricing governance. The engagement account identifies A$2.7m–4.2m of margin improvement potential, not realised financial benefit.

Results at a glance

Client: Boston Scientific ANZ.
Status: Identified opportunity.
Margin potential: A$2.7m–4.2m across selected categories.
Outputs: Customer value canvases, commercial education, governance designs and an improvement roadmap.

Client context

Boston Scientific’s ANZ website organises products and solutions by medical specialty. Different applications involve different users and purchasing priorities, making a single generic premium-product argument insufficient. Current website information is contextual, not proof of historical project outcomes.

What pricing challenge did the teams face?

Historical deal anchors and inconsistent discount decisions made price execution uneven. Technical product knowledge was strong, but clinical and operational benefits were not consistently translated into commercial arguments or tender responses.

What did Pricing Insight do?

Pricing Insight delivered diagnostic and margin-planning workshops, facilitated customer-value mapping and provided pricing-maths and negotiation education. Discount-governance workflows and an improvement roadmap connected frontline decisions with leadership priorities.

What changed or was identified?

The project account describes shared value tools, improved alignment and identified margin potential.

How was the opportunity measured?

A$2.7m–4.2m is identified potential. The public account does not disclose the full sizing calculation, a reconciled realised profit result or independent validation. This case study does not establish clinical performance claims or patient outcomes.

Pricing Insight Periodic Table: relevant capabilities

Value quantification (Vq), Pricing playbook (Pb) and Discount authority and controls (Da) provide a retrospective explanation using the current framework, not a measured scorecard.

Lessons for similar businesses

Connect technical differentiation to the priorities of each buyer, support that argument with evidence and set consistent discount authorities. Measure any later financial benefit separately.